What’s Next for Obesity Therapeutics? Higher Quality Weight Loss
Pictured: A collage of injectable drugs, a scale and a BMI chart/Taylor Tieden for BioSpace GLP-1 agonists are set to become the best-selling drugs in 2024, but the biopharma industry isn’t resting on its collective laurels. Instead, some companies …